Kozielewicz, D., Grabińska, A., Madej, G., & Wietlicka-Piszcz, M. (2018). Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4. Prz Gastroenterol.
Chicago Stili AlıntıKozielewicz, Dorota, Anna Grabińska, Grzegorz Madej, ve Magdalena Wietlicka-Piszcz. "Efficacy and Safety of Pegylated Interferon α and Ribavirin in Patients Monoinfected With HCV Genotype 4." Prz Gastroenterol 2018.
MLA AlıntıKozielewicz, Dorota, Anna Grabińska, Grzegorz Madej, ve Magdalena Wietlicka-Piszcz. "Efficacy and Safety of Pegylated Interferon α and Ribavirin in Patients Monoinfected With HCV Genotype 4." Prz Gastroenterol 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..